Neurosciences - May 2013 Archives

Blood offers promise as a way to detect Alzheimer's disease at its earliest onset. Mayo Clinic researchers say they envision a test that would detect distinct ...

Devices snaked into the brain artery of a patient experiencing a stroke should primarily be used within a clinical trial setting. Vascular neurologists at Mayo Clinic ...

This is National Stroke Awareness Month. Stroke is a leading cause of death in the United States, killing nearly 130,000 Americans each year — that’s 1 of every ...

On Saturday Robert Brown Jr., M.D., will join us to talk about stroke prevention. Stroke is the fourth leading cause of death in the United States, claims ...

Researchers at Mayo Clinic have completed the world’s first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy. Mayo oncologist and lead author Michaela Banck, M.D., says, “This is a very important step in achieving targeted therapies and individualized treatment approaches for patients with small bowel carcinoids. Genomic analysis of the individual patient’s tumors will help us identify new drugs that are targeted to the individual’s disease.” Click here for news release

SCOTTSDALE, Ariz. — Every day, thousands of volunteer medical relief groups offer care to patients and assistance to understaffed medical teams in remote, underdeveloped locations ...

Brain tumors strike at any age and can be malignant or benign. This week we'll talk with neuro surgeon Michael Link, M.D., and neurologist Alyx Porter, M.D., about symptoms, diagnoses, treatments, ...